Skip to content

Venture

Blank-300x300

Affiliations

SUNY

Technologies

Diagnostic

Therapeutic

Indication

Drug Discovery

Metabolic Disease

Additional Information

Women Founded

MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer.

MedHexim1 Team:

Eduardo Mascareno, PhD, President

Manya Dhar-Mascareno, President